These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32709242)

  • 21. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN
    Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, double-blind, hemodynamic evaluation of nifedipine and labetalol in preeclamptic hypertensive emergencies.
    Scardo JA; Vermillion ST; Newman RB; Chauhan SP; Hogg BB
    Am J Obstet Gynecol; 1999 Oct; 181(4):862-6. PubMed ID: 10521743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenously administered labetalol for treatment of hypertension in children.
    Bunchman TE; Lynch RE; Wood EG
    J Pediatr; 1992 Jan; 120(1):140-4. PubMed ID: 1731011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of the effects of combined or separate alpha- and beta-blockade in the treatment of hypertension in the acute stage of myocardial infarction.
    Renard M; Jacobs P; Liebens I; Abou Hamdam B; Bernard R
    Int J Cardiol; 1986 Feb; 10(2):149-58. PubMed ID: 3080379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacologic reduction of mean arterial pressure does not adversely affect regional cerebral blood flow and intracranial pressure in experimental intracerebral hemorrhage.
    Qureshi AI; Wilson DA; Hanley DF; Traystman RJ
    Crit Care Med; 1999 May; 27(5):965-71. PubMed ID: 10362421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood pressure reduction by incremental infusion of labetalol in patients with severe hypertension.
    Cummings AM; Brown JJ; Fraser R; Lever AF; Morton JJ; Richards DA; Robertson JI
    Br J Clin Pharmacol; 1979 Oct; 8(4):359-64. PubMed ID: 508511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial.
    Vigil-De Gracia P; Lasso M; Ruiz E; Vega-Malek JC; de Mena FT; López JC;
    Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):157-62. PubMed ID: 16621226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe labetalol overdose in an 8-month-old infant.
    Thorsteinsson A; Johannesdottir A; Eiríksson H; Helgason H
    Paediatr Anaesth; 2008 May; 18(5):435-8. PubMed ID: 18312512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood pressure reduction in hypertensive acute ischemic stroke patients does not affect cerebral blood flow.
    Kate M; Asdaghi N; Gioia LC; Buck B; Majumdar SR; Jeerakathil T; Shuaib A; Emery D; Beaulieu C; Butcher K
    J Cereb Blood Flow Metab; 2019 Sep; 39(9):1878-1887. PubMed ID: 29737226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preliminary experience of using fixed dose of intravenous labetalol in surgical resection of pheochromocytoma.
    Chung PC; Sum DC
    Ma Zui Xue Za Zhi; 1993 Dec; 31(4):211-6. PubMed ID: 8302145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High dose intravenous labetalol for the resection of metastatic pheochromocytoma.
    Chung PC; Sum DC; Wu RS
    Acta Anaesthesiol Sin; 1996 Dec; 34(4):235-8. PubMed ID: 9084552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of exercise on intra-arterial blood pressure and pulse rate before and during long-term high-dose treatment with labetalol in patients with severe, therapy-resistant hypertension.
    la Cour Petersen E; Kristensen BO
    Postgrad Med J; 1980; 56 Suppl 2():60-4. PubMed ID: 7433345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Labetalol infusion in acute myocardial infarction with systemic hypertension.
    Marx PG; Reid DS
    Br J Clin Pharmacol; 1979; 8(Suppl 2):233S-238S. PubMed ID: 526407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Labetalol as a hypotensive agent in otological operations.
    Pakkanen A; Kanto J
    Ann Chir Gynaecol; 1979; 68(2):82-3. PubMed ID: 41475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical evaluation of intravenous labetalol for the treatment of hypertensive urgency.
    Huey J; Thomas JP; Hendricks DR; Wehmeyer AE; Johns LJ; MacCosbe PE
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):284S-289S. PubMed ID: 3415804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute haemodynamic effects of labetalol and its subsequent use of an oral hypotensive agent.
    Joekes AM; Thompson FD
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):789-93. PubMed ID: 990156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid onset of action of oral labetalol in severe hypertension.
    Ghose RR; Sampson A
    Curr Med Res Opin; 1977; 5(2):147-51. PubMed ID: 340130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of arterial hypertension with labetalol. A polycentric study].
    G Ital Cardiol; 1982; 12(10):729-35. PubMed ID: 7182212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Labetalol in the treatment of essential hypertension: a single-blind dose ranging study.
    Dux S; Grosskopf I; Boner G; Rosenfeld JB
    J Clin Pharmacol; 1986; 26(5):346-50. PubMed ID: 3700690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of high-dose intravenous labetalol in hypertensive crisis.
    Hecht JP; Mahmood SM; Brandt MM
    Am J Health Syst Pharm; 2019 Feb; 76(5):286-292. PubMed ID: 30753292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.